Treatment outcome of Singapore residents with pulmonary tuberculosis in the first year after introduction of a computerised treatment surveillance module

Singapore Medical Journal

Volumn 47, Issue 6, 2006, Pages 529-533

  Chee, Cynthia B E ^a   Wang, Y T ^a   Teleman, M D ^b   Boudville, I C ^b   Chew, S K ^c  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b Department of Clinical Epidemiology ^*

^c MINISTRY OF HEALTH   (Singapore)

Author keywords

Directly observed therapy; Pulmonary; Treatment outcome; Tuberculosis

Indexed keywords

ADULT; ARTICLE; CHINESE; COMPUTER ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; ETHNOLOGY; FOLLOW UP; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MORTALITY; PHYSICIAN; RISK; SINGAPORE; TREATMENT OUTCOME;

ANTITUBERCULAR AGENTS; COMPUTER SYSTEMS; DIRECTLY OBSERVED THERAPY; DISEASE NOTIFICATION; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SINGAPORE; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 33745149301     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Maher D, Mikulencak M. What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. Geneva: World Health Organization; 1999. WHO document WHO/CDS/CPC/TB99.270.
2. Chee CBE, Wang YT. Political will - the Singapore Tuberculosis Elimination Programme. In: Reichman LB, Hershfield ES, eds. Tuberculosis: A Comprehensive International Approach. Lung Biology in Health and Disease series. 2nd ed. New York: Marcel Dekker Inc. 2000:727-44.
3. Chee CBE, James L. The Singapore Tuberculosis Elimination Programme: the first five years. Bull World Health Organ 2003; 81:217-21.
4. Communicable Disease Centre. Tan Tock Seng Hospital Annual Report, 1997. Singapore.
5. HIV/STI and TB Surveillance Report, 2003.
6. Communicable Disease Centre. Tan Tock Seng Hospital Annual Report, 2001. Singapore.
7. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72:1-6.
8. Ormerod LP, Prescott RJ. The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998. Clin Med 2003; 3:57-61.
9. Migliori GB, Ambrosetti M, Besozzi G, et al. Cohort analysis of anti-tuberculosis treatment results in Italy. Progress Report, First Research Project Tuberculosis, Instituto Superiore di sanit B. Rapporti ISTSAN 1997; 97:141.
10. Netherlands Tuberculosis Register. Index Tuberculosis 1996. Den Haag: KNCV, 1997.
11. Chee CBE, Boudville IC, Chan SP, Zee YK, Wang YT. Patient and disease characteristics, and outcome of treatment defaulters from the Singapore TB Control Unit - a one-year retrospective survey. Int J Tuberc Lung Dis 2000; 4:496-503.
12. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167:603-62.
13. Comment in: Am J Respir Crit Care Med 2004; 169:316-7.
14. Enarson D A, Rieder H L. Management of tuberculosis: a guide for low income countries. 5th ed. Paris: International Union Against Tuberculosis and Lung Disease, 2000.
15. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998; 352: 1340-3.
16. Walley JD, Khan MA, Newell J, Khan MH. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001; 357:664-9.
17. Comment in: ACP J Club 2001; 135:67,
18. Lancet 2001; 358:420-2,
19. Lancet 2001; 357:1708.
20. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 chinese patients with smear-positive tuberculosis. Lancet 1996; 347:358-62.
21. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330:1179-84.
22. Comment in: N Engl J Med 1994; 330:1229-30.
23. Freiden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333:229-33.